Long‐Term Safety and Efficacy of Anifrolumab in Adults With Systemic Lupus Erythematosus: Results of a Phase II Open‐Label Extension Study

OBJECTIVE: To investigate long‐term safety and tolerability of anifrolumab, a human monoclonal antibody to the type I interferon (IFN) receptor subunit 1, in patients with moderate‐to‐severe systemic lupus erythematosus (SLE). METHODS: This 3‐year, multinational, open‐label extension study included...

全面介紹

Na minha lista:
書目詳細資料
發表在:Arthritis Rheumatol
Main Authors: Chatham, W. Winn, Furie, Richard, Saxena, Amit, Brohawn, Philip, Schwetje, Erik, Abreu, Gabriel, Tummala, Raj
格式: Artigo
語言:Inglês
出版: John Wiley and Sons Inc. 2021
主題:
Systemic Lupus Erythematosus
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC8252065/
https://ncbi.nlm.nih.gov/pubmed/33225631
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.41598
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍